Sagility Acquires CareSeed to Boost AI-Led Quality Operations
Sagility Limited acquired CareSeed, a U.S. healthcare analytics firm, to enhance AI-led quality operations and Medicare Advantage performance. The deal aims to integrate CareSeed's HEDIS reporting and analytics platforms with Sagility's capabilities. CareSeed reported $5.1M (₹42.5 crore) revenue in CY25. The acquisition is expected to close on June 11, 2026.
The acquisition significantly expands Sagility's service offerings and market position in the healthcare analytics and quality operations sector, particularly within the Medicare Advantage segment, which is a substantial market.
The acquisition is expected to be EPS accretive and enhances Sagility's capabilities in a key market, indicating positive future growth and strategic alignment.
Sagility Limited has announced its acquisition of CareSeed, a U.S.-based healthcare analytics company specializing in NCQA-certified HEDIS quality reporting, medical record review, chart abstraction, and regulatory analytics for health plans. Founded in 2012 and headquartered in Kansas City, Missouri, CareSeed serves 30 small and mid-sized U.S. payers, with a strong focus on Medicare Advantage.
CareSeed's cloud-native platforms, Forecast and Harvest, are designed to help health plans improve HEDIS performance, streamline chart abstraction and medical record review, strengthen audit readiness, and manage complex regulatory requirements. This acquisition is a strategic move for Sagility to expand its healthcare quality and Stars capabilities, aiming to move health plans beyond retrospective HEDIS reporting towards integrated, member-level quality orchestration. The combined entity will offer an end-to-end quality operations continuum, supporting health plans throughout the full quality lifecycle.
Ramesh Gopalan, Managing Director and Group Chief Executive Officer of Sagility, stated that the combination of CareSeed's technology with Sagility's capabilities will create a more connected quality operations model, helping health plans identify and close care gaps earlier, improve member outcomes, enhance Star Ratings, and drive sustainable financial results. Thomas Mueller, CEO of CareSeed, noted that joining Sagility enables them to combine their specialized quality analytics with Sagility’s operational scale and transformation capabilities to deliver greater value.
The acquisition is expected to be EPS accretive and is anticipated to close on June 11, 2026. Houlihan Lokey served as the exclusive financial advisor to CareSeed. CareSeed reported revenues of $5.1 million (₹42.5 crore) in CY25 with an EBITDA of $1.6 million (₹13.36 crore) at a 31.4% EBITDA margin.
What to do with a filing like this
SAGILITY LIMITED filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SAGILITY LIMITED. Read the original for the full detail.